These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

52 related items for PubMed ID: 3329903

  • 1. Increased release of prostacyclin-like activity from rat aorta by plasma from patients with hepatic or renal failure.
    Chamone DA, Van Hoof A, Vermylen J.
    Arq Gastroenterol; 1987; 24(1):16-9. PubMed ID: 3329903
    [Abstract] [Full Text] [Related]

  • 2. Prostacyclin synthesis is stimulated by a serum factor formed during coagulation.
    Ritter JM, Ongari MA, Orchard MA, Lewis PJ.
    Thromb Haemost; 1983 Feb 28; 49(1):58-60. PubMed ID: 6342202
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Endothelial dysfunction in patients with kidney failure and vascular risk factors: acute effects of hemodialysis.
    Migliacci R, Falcinelli F, Imperiali P, Floridi A, Nenci GG, Gresele P.
    Ital Heart J; 2004 May 28; 5(5):371-7. PubMed ID: 15185901
    [Abstract] [Full Text] [Related]

  • 7. Reversible deficient prostacyclin release in childhood hemolytic uremic syndrome.
    Chamone DA, Proesmans WC, Monnens LA, Binda ki Muaka P, Vermylen JG.
    Int J Pediatr Nephrol; 1982 Mar 28; 3(1):13-6. PubMed ID: 7049977
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Decreased platelet sensitivity to prostacyclin (epoprostenol) during hemodialysis.
    Kristensen SD, Knudsen F, Nielsen AH, Ring T.
    Clin Nephrol; 1984 Apr 28; 21(4):230-4. PubMed ID: 6375926
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [Arterial hypertension in patients on chronic hemodialysis].
    Zogović J, Mladenović Lj.
    Srp Arh Celok Lek; 1996 Apr 28; 124(9-10):246-50. PubMed ID: 9102857
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Platelet surface receptor activation in patients with chronic renal failure on hemodialysis, peritoneal dialysis and those with successful kidney transplantation.
    Ballow A, Gader AM, Huraib S, Al-Husaini K, Mutwalli A, Al-Wakeel J.
    Platelets; 2005 Feb 28; 16(1):19-24. PubMed ID: 15763892
    [Abstract] [Full Text] [Related]

  • 16. Prostaglandin synthesis in aorta and platelets of fawn-hooded rats with platelet storage pool disease and its response to cholesterol feeding.
    Wey H, Gallon L, Subbiah MT.
    Thromb Haemost; 1982 Aug 24; 48(1):94-7. PubMed ID: 6890244
    [Abstract] [Full Text] [Related]

  • 17. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L.
    Dan Med Bull; 2008 Nov 24; 55(4):186-210. PubMed ID: 19232159
    [Abstract] [Full Text] [Related]

  • 18. Decreased stabilization of prostacyclin activity in patients with bone tumors.
    Mehta P, Ostrowski N, Brigmon L.
    Cancer Res; 1984 Jul 24; 44(7):3132-4. PubMed ID: 6373003
    [Abstract] [Full Text] [Related]

  • 19. Vascular trauma and prostacyclin release.
    Jeremy JY, Mikhailidis DP, Dandona P.
    Microcirc Endothelium Lymphatics; 1984 Oct 24; 1(5):629-44. PubMed ID: 6400432
    [Abstract] [Full Text] [Related]

  • 20. Prostacyclin and thromboxane in chronic uremia: effect of hemodialysis.
    Ylikorkala O, Huttunen K, Järvi J, Viinikka L.
    Clin Nephrol; 1982 Aug 24; 18(2):83-7. PubMed ID: 6754193
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 3.